Laboratory Specialists of America Inc

Indentures Filter

EX-4.6
from S-4 8 pages Sixteenth Supplemental Indenture
12/34/56
EX-4.21
from S-4/A 9 pages Eleventh Supplemental Indenture (This “Supplemental Indenture”), Dated as of March 19, 2010, Among New Binax, Inc., New Biosite Incorporated, Alere Newco, Inc., and Alere Newco II, Inc. ( the “New Guarantors”), Subsidiaries of Inverness Medical Innovations, Inc. (Or Its Successor) (The “Issuer”), Inverness Medical Innovations, Inc., a Delaware Corporation, Each of the Guarantors (The “Existing Guarantors”) Under the Indenture Referred to Below, and the Bank of New York Mellon Trust Company, N.A., as Trustee Under the Indenture Referred to Below (The “Trustee”)
12/34/56
EX-4.20
from S-4/A 9 pages Tenth Supplemental Indenture (This “Supplemental Indenture”), Dated as of March 19, 2010, Among New Binax, Inc., New Biosite Incorporated, Alere Newco, Inc., and Alere Newco II, Inc. (The “New Guarantors”), Subsidiaries of Inverness Medical Innovations, Inc. (Or Its Successor) (The “Issuer”), Inverness Medical Innovations, Inc., a Delaware Corporation, Each of the Guarantors (The “Existing Guarantors”) Under the Indenture Referred to Below, and the Bank of New York Mellon Trust Company, N.A., as Trustee Under the Indenture Referred to Below (The “Trustee”)
12/34/56
EX-4.19
from S-4/A 8 pages Ninth Supplemental Indenture (This “Supplemental Indenture”), Dated as of March 1, 2010, Among Laboratory Specialists of America, Inc., Kroll Laboratory Specialists, Inc., and Scientific Testing Laboratories, Inc. ( the “New Guarantors”), Subsidiaries of Inverness Medical Innovations, Inc. (Or Its Successor) (The “Issuer”), Inverness Medical Innovations, Inc., a Delaware Corporation, Each of the Guarantors (The “Existing Guarantors”) Under the Indenture Referred to Below, and the Bank of New York Mellon Trust Company, N.A., as Trustee Under the Indenture Referred to Below (The “Trustee”)
12/34/56
EX-4.18
from S-4/A 8 pages Eighth Supplemental Indenture (This “Supplemental Indenture”), Dated as of March 1, 2010, Among Laboratory Specialists of America, Inc., Kroll Laboratory Specialists, Inc., and Scientific Testing Laboratories, Inc. (The “New Guarantors”), Subsidiaries of Inverness Medical Innovations, Inc. (Or Its Successor) (The “Issuer”), Inverness Medical Innovations, Inc., a Delaware Corporation, Each of the Guarantors (The “Existing Guarantors”) Under the Indenture Referred to Below, and the Bank of New York Mellon Trust Company, N.A., as Trustee Under the Indenture Referred to Below (The “Trustee”)
12/34/56
EX-4.9
from 8-A12B 8 pages Seventh Supplemental Indenture (This “Supplemental Indenture”), Dated as of March 1, 2010, Among Laboratory Specialists of America, Inc., Kroll Laboratory Specialists, Inc. and Scientific Testing Laboratories, Inc. (Collectively, the “New Guarantors”), Subsidiaries of Inverness Medical Innovations, Inc. (Or Its Successor) (The “Issuer”), Inverness Medical Innovations, Inc., a Delaware Corporation, Each of the Guarantors (The “Existing Guarantors”) Under the Indenture Referred to Below, and U.S. Bank National Association, as Trustee Under the Indenture Referred to Below (The “Trustee”)
12/34/56
EX-4.6
from SB-2/A ~10 pages Indenture or similar
12/34/56
EX-4.3
from SB-2 ~10 pages Indenture or similar
12/34/56
EX-4.2
from S-8 ~10 pages Indenture or similar
12/34/56
EX-4.2
from S-8 ~20 pages Indenture or similar
12/34/56
EX-4.8
from SB-2/A ~10 pages Common Stock Purchase Warrant
12/34/56
EX-4.5
from SB-2/A ~10 pages Form of Warrant for Purchase
12/34/56
EX-4.7
from SB-2 ~20 pages 1994 Sop Amended & Restated October 30, 1996
12/34/56
EX-4.5
from SB-2 ~10 pages Form of Warrant for Puchase of Common Stock
12/34/56